Home/Pipeline/Hummingbird ICP Monitoring Commercialization

Hummingbird ICP Monitoring Commercialization

Intracranial Pressure (ICP) Monitoring

CommercialActive

Key Facts

Indication
Intracranial Pressure (ICP) Monitoring
Phase
Commercial
Status
Active
Company

About IRRAS

IRRAS is a commercial-stage medical device company targeting critical needs in neurocritical care. Its flagship IRRAflow system differentiates itself from traditional passive drainage by offering automated, controlled, and monitored fluid management, aiming to improve patient outcomes and reduce complications. The company also markets the Hummingbird ICP monitoring product line, expanding its footprint in the neurosurgical ICU. While commercial, IRRAS operates in a competitive and reimbursement-sensitive market, requiring continued clinical validation and market penetration to achieve sustainable growth.

View full company profile